Human Milk Oligosaccharides Market Report Provide Recent Trends, Opportunity, Forecast 2025-2032

Human Milk Oligosaccharides Market size was estimated at USD 303.52 Mn in 2024 and the total Global Human Milk Oligosaccharides Market revenue is projected to grow at a CAGR of 23.5% from 2025 to 2032, reaching nearly USD 1642.57 Mn by 2032.

Stellar Market Research has released a report "Human Milk Oligosaccharides Market and forecast (2025-2032)." The report is a detailed analysis of the global market share, size, growth, trends, and forecast of Human Milk Oligosaccharides. It also includes competitor and regional analysis and focuses on the recent trend in the market.

Download your complimentary sample copy of this report! https://www.stellarmr.com/report/req_sample/human-milk-oligosaccharides-market/2667

Drivers of the Human Milk Oligosaccharides Market
Increasing Infant Population to Drive the Human Milk Oligosaccharides Market
One of the most influential factor in determining Human Milk Oligosaccharides Market is the growing infant population worldwide, particularly in developing and emerging economics. HMO as the third most prevalent solid constituent of human breast milk after lactose and lipids, have been found to aid in the development of immune systems, enhance the development of beneficial bacteria of the gut, and prevent infants from infections and diseases.

High Production Cost to Restrain the Human Milk Oligosaccharides Market
The HMO market expands beyond infant nutrition with research identifying their uses in adults' gut health and immunity. HMOs function as prebiotics, supporting gut bacteria that maintain healthy digestion, inflammation reduction, and immunity stimulation. This has extended their applications in dietary supplements, functional foods, and medical nutrition to adults.

To learn more about the findings of this research, please check: https://www.stellarmr.com/report/human-milk-oligosaccharides-market/2667

Human Milk Oligosaccharides Market Segmentation
By Type
Out of all HMO types, 2'-Fucosyllactose has the highest market share. It is the most common HMO in human breast milk and out of all HMO, it is first to receive regulatory approvals for use in infant formula. It is best known for its immune health and gut microbiota benefits. Others such as Lacto-N-neotetraose and 3'-Fucosyllactose are becoming more popular, particularly among those products seeking to emulate the complexity of human milk.

By Source
The Human Milk Oligosaccharides market is divided by source into chemical synthesis, enzymatic synthesis, and microbial fermentation. Out Of these, microbial fermentation leads the market because of its economic feasibility, scalability, and capability of producing complex HMOs such as 2'-FL at commercial quantities. Enzymatic synthesis is being explored based on precision but is utilized less because it is more costly, while chemical synthesis is the least utilized and is primarily reserved for research purposes because of its complexity and cost.

Human Milk Oligosaccharides Market Regional Analysis
North America
North America dominates the market because of early approval by regulations, particularly from the FDA, to have HMOs such as 2'-Fucosyllactose included in infant formula. The high consumer knowledge regarding infant nutrition and gut health, as well as the existence of top biotech and nutritional companies investing aggressively in research and development, which enables innovation and growth in the market.

Asia Pacific
The Asia-Pacific market is the fastest-growing market for HMOs, fueled by high birth rates, growth of the middle class, and a growing health consciousness. The China and India markets have shown growing demand for premium infant nutrition products, supported by growing urbanization, better disposable incomes, and a growing level of availability of scientifically formulated formulas and functional foods.

Grab your free sample copy of this report today! https://www.stellarmr.com/report/req_sample/human-milk-oligosaccharides-market/2667

Europe
Europe stands in the third position in the Human Milk Oligosaccharide Market as a result of the encouraging regulatory climate, including European Food Safety Authority approvals, and consumer demand for premium, organic, and science-based infant nutrition products.

Middle East & Affrica
The Middle East & Africa region is slowly emerging as a market for HMOs, backed by enhancing healthcare infrastructure and growing consumer healthcare awareness. Growth, though slower in comparison to other regions, is being pushed by growing modern retail chains and imports of high-quality infant nutrition products.

Human Milk Oligosaccharides Market Competitive Landscape
Chr. Hansen, Novozymes Merger to Form Novonesis: Chr. Hansen A/S and Novozymes A/S merged in January 2024 to become Novonesis, an organization that aims to be a global market leader in sustainable solutions for food, health, and environment sectors. From this merge, Chr. Hansen's solid microbial solution portfolio is supplemented with Novozymes' enzymatic production capacity, further enhancing their research and development on HMO.

BASF and Chr. Hansen Strategic Cooperation: BASF SE and Chr. Hansen Holding A/S signed a strategic cooperation for co-development and marketing of new HMO solutions for infant nutrition in November 2023. The two companies use their respective strengths in fermentation technology and HMO research to produce new and better HMO products for markets under this partnership.

Look at Today's Top Trends :
Pea Protein Market https://www.stellarmr.com/report/Pea-Protein-Market/1656

Oyster And Clam Market https://www.stellarmr.com/report/Oyster-and-Clam-Market/1698

Recent Development
In 2023: DSM-Firmenich launched Lacnativ 2'-FL in December 2023, a novel HMO ingredient that will help infant gut health and immune system development by fostering the growth of beneficial bacteria and discouraging harmful pathogens.

In 2024: A European biotech firm reported in February 2024 a breakthrough in synthetic HMO manufacturing techniques, allowing the inexpensive, industrial-scale manufacture of HMOs for several uses.

For more information, please contact:
Stellar Market Research:
S.no.8, h.no. 4-8 Pl.7/4, Kothrud,
Pinnac Memories Fl. No. 3, Kothrud, Pune,
Pune, Maharashtra, 411029
sales@stellarmr.com

About Stellar Market Research:
Stellar Market Research is a global leader in market research and consulting services, specializing in a wide range of industries, including healthcare, technology, automobiles, electronics, and more. With a team of experts, Stellar Market Research provides data-driven market insights, strategic analysis, and competition evaluation to help businesses make informed decisions and achieve success in their respective industries.

This release was published on openPR.